Nanoparticles as potential clinical therapeutic agents in Alzheimer’s disease: focus on selenium nanoparticles

Introduction: In etiology of Alzheimer’s disease (AD), involvement of amyloid β (Aβ) plaque accumulation and oxidative stress in the brain have important roles. Several nanoparticles such as titanium dioxide, silica dioxide, silver and zinc oxide have been experimentally using for treatment of neuro...

Full description

Bibliographic Details
Published in:Expert Review of Clinical Pharmacology
Main Author: 2-s2.0-85021103809
Format: Review
Language:English
Published: Taylor and Francis Ltd 2017
Online Access:https://www.scopus.com/inward/record.uri?eid=2-s2.0-85021103809&doi=10.1080%2f17512433.2017.1324781&partnerID=40&md5=c4279183e800673b1cd805c82ffadca3

Similar Items